Hydrolysis of cis- and trans-epoxyeicosatrienoic acids by rat red blood cells

Houli Jiang, Angela G. Zhu, Magdalena Mamczur, Christophe Morisseau, Bruce D. Hammock, John R. Falck, John C. McGiff

Research output: Contribution to journalArticle

22 Citations (Scopus)

Abstract

Erythrocytes serve as reservoirs for cis- and trans-epoxyeicosatrienoic acids (EETs). Incubation of rat red blood cells (RBCs) with cis- and trans-EETs produces threo- and erythro-dihydroxyeicosatrienoic acids, respectively. The Vmax of EET hydrolysis by rat intact RBCs (2.35 ± 0.24 pmol/min/108 RBCs for 14,15-trans-EET) decreased by approximately 2 to 3-fold sequentially from 14,15-, 11,12- to 8,9-EETs for both cis- and trans-isomers. The Vmax of trans-EET hydrolysis by RBCs is approximately 2 to 3 times that of the corresponding cis-EETs. Incubation of EETs with recombinant murine soluble epoxide hydrolase (sEH) yielded the same geometric and regio preferences of EET hydrolysis as with rat intact RBCs. The principal epoxide hydrolase activity for EET hydrolysis (approximately 90%) is present in the erythrocyte cytosol. Western blots of sEH suggested a concentration of sEH protein to be approximately 2 μg/mg protein or 0.4 μg/109 RBCs. The apparent Km values of EETs were between 1 and 2 μM, close to the Km for purified sEH as reported. Erythrocyte hydration of cis- and trans-EETs was blocked by sEH inhibitors, 1,3-dicyclohexylurea and 4-[4-(3-adamantan-1-ylureido)cyclohexyloxy]benzoic acid. Erythrocyte sEH activity was inhibited more than 80% by 0.2% bovine serum albumin in the buffer. Preferred hydrolysis of 14,15-EETs and trans-epoxides characterizes sEH activity in RBCs that regulates the hydrolysis and release of cis- and trans-EETs in the circulation. Inhibition of sEH has produced antihypertensive and antiinflammatory effects. Because plasma trans-EETs would increase more than cis-EETs with sEH inhibition, the potential roles of trans-EETs and erythrocyte sEH in terms of circulatory regulation deserve attention.

Original languageEnglish (US)
Pages (from-to)330-337
Number of pages8
JournalJournal of Pharmacology and Experimental Therapeutics
Volume326
Issue number1
DOIs
StatePublished - Jul 2008

Fingerprint

lissamine rhodamine B
Epoxide Hydrolases
Hydrolysis
Erythrocytes

ASJC Scopus subject areas

  • Pharmacology

Cite this

Jiang, H., Zhu, A. G., Mamczur, M., Morisseau, C., Hammock, B. D., Falck, J. R., & McGiff, J. C. (2008). Hydrolysis of cis- and trans-epoxyeicosatrienoic acids by rat red blood cells. Journal of Pharmacology and Experimental Therapeutics, 326(1), 330-337. https://doi.org/10.1124/jpet.107.134858

Hydrolysis of cis- and trans-epoxyeicosatrienoic acids by rat red blood cells. / Jiang, Houli; Zhu, Angela G.; Mamczur, Magdalena; Morisseau, Christophe; Hammock, Bruce D.; Falck, John R.; McGiff, John C.

In: Journal of Pharmacology and Experimental Therapeutics, Vol. 326, No. 1, 07.2008, p. 330-337.

Research output: Contribution to journalArticle

Jiang, H, Zhu, AG, Mamczur, M, Morisseau, C, Hammock, BD, Falck, JR & McGiff, JC 2008, 'Hydrolysis of cis- and trans-epoxyeicosatrienoic acids by rat red blood cells', Journal of Pharmacology and Experimental Therapeutics, vol. 326, no. 1, pp. 330-337. https://doi.org/10.1124/jpet.107.134858
Jiang, Houli ; Zhu, Angela G. ; Mamczur, Magdalena ; Morisseau, Christophe ; Hammock, Bruce D. ; Falck, John R. ; McGiff, John C. / Hydrolysis of cis- and trans-epoxyeicosatrienoic acids by rat red blood cells. In: Journal of Pharmacology and Experimental Therapeutics. 2008 ; Vol. 326, No. 1. pp. 330-337.
@article{1e401c2e90ce4d8b9d0c344381e6d3ee,
title = "Hydrolysis of cis- and trans-epoxyeicosatrienoic acids by rat red blood cells",
abstract = "Erythrocytes serve as reservoirs for cis- and trans-epoxyeicosatrienoic acids (EETs). Incubation of rat red blood cells (RBCs) with cis- and trans-EETs produces threo- and erythro-dihydroxyeicosatrienoic acids, respectively. The Vmax of EET hydrolysis by rat intact RBCs (2.35 ± 0.24 pmol/min/108 RBCs for 14,15-trans-EET) decreased by approximately 2 to 3-fold sequentially from 14,15-, 11,12- to 8,9-EETs for both cis- and trans-isomers. The Vmax of trans-EET hydrolysis by RBCs is approximately 2 to 3 times that of the corresponding cis-EETs. Incubation of EETs with recombinant murine soluble epoxide hydrolase (sEH) yielded the same geometric and regio preferences of EET hydrolysis as with rat intact RBCs. The principal epoxide hydrolase activity for EET hydrolysis (approximately 90{\%}) is present in the erythrocyte cytosol. Western blots of sEH suggested a concentration of sEH protein to be approximately 2 μg/mg protein or 0.4 μg/109 RBCs. The apparent Km values of EETs were between 1 and 2 μM, close to the Km for purified sEH as reported. Erythrocyte hydration of cis- and trans-EETs was blocked by sEH inhibitors, 1,3-dicyclohexylurea and 4-[4-(3-adamantan-1-ylureido)cyclohexyloxy]benzoic acid. Erythrocyte sEH activity was inhibited more than 80{\%} by 0.2{\%} bovine serum albumin in the buffer. Preferred hydrolysis of 14,15-EETs and trans-epoxides characterizes sEH activity in RBCs that regulates the hydrolysis and release of cis- and trans-EETs in the circulation. Inhibition of sEH has produced antihypertensive and antiinflammatory effects. Because plasma trans-EETs would increase more than cis-EETs with sEH inhibition, the potential roles of trans-EETs and erythrocyte sEH in terms of circulatory regulation deserve attention.",
author = "Houli Jiang and Zhu, {Angela G.} and Magdalena Mamczur and Christophe Morisseau and Hammock, {Bruce D.} and Falck, {John R.} and McGiff, {John C.}",
year = "2008",
month = "7",
doi = "10.1124/jpet.107.134858",
language = "English (US)",
volume = "326",
pages = "330--337",
journal = "Journal of Pharmacology and Experimental Therapeutics",
issn = "0022-3565",
publisher = "American Society for Pharmacology and Experimental Therapeutics",
number = "1",

}

TY - JOUR

T1 - Hydrolysis of cis- and trans-epoxyeicosatrienoic acids by rat red blood cells

AU - Jiang, Houli

AU - Zhu, Angela G.

AU - Mamczur, Magdalena

AU - Morisseau, Christophe

AU - Hammock, Bruce D.

AU - Falck, John R.

AU - McGiff, John C.

PY - 2008/7

Y1 - 2008/7

N2 - Erythrocytes serve as reservoirs for cis- and trans-epoxyeicosatrienoic acids (EETs). Incubation of rat red blood cells (RBCs) with cis- and trans-EETs produces threo- and erythro-dihydroxyeicosatrienoic acids, respectively. The Vmax of EET hydrolysis by rat intact RBCs (2.35 ± 0.24 pmol/min/108 RBCs for 14,15-trans-EET) decreased by approximately 2 to 3-fold sequentially from 14,15-, 11,12- to 8,9-EETs for both cis- and trans-isomers. The Vmax of trans-EET hydrolysis by RBCs is approximately 2 to 3 times that of the corresponding cis-EETs. Incubation of EETs with recombinant murine soluble epoxide hydrolase (sEH) yielded the same geometric and regio preferences of EET hydrolysis as with rat intact RBCs. The principal epoxide hydrolase activity for EET hydrolysis (approximately 90%) is present in the erythrocyte cytosol. Western blots of sEH suggested a concentration of sEH protein to be approximately 2 μg/mg protein or 0.4 μg/109 RBCs. The apparent Km values of EETs were between 1 and 2 μM, close to the Km for purified sEH as reported. Erythrocyte hydration of cis- and trans-EETs was blocked by sEH inhibitors, 1,3-dicyclohexylurea and 4-[4-(3-adamantan-1-ylureido)cyclohexyloxy]benzoic acid. Erythrocyte sEH activity was inhibited more than 80% by 0.2% bovine serum albumin in the buffer. Preferred hydrolysis of 14,15-EETs and trans-epoxides characterizes sEH activity in RBCs that regulates the hydrolysis and release of cis- and trans-EETs in the circulation. Inhibition of sEH has produced antihypertensive and antiinflammatory effects. Because plasma trans-EETs would increase more than cis-EETs with sEH inhibition, the potential roles of trans-EETs and erythrocyte sEH in terms of circulatory regulation deserve attention.

AB - Erythrocytes serve as reservoirs for cis- and trans-epoxyeicosatrienoic acids (EETs). Incubation of rat red blood cells (RBCs) with cis- and trans-EETs produces threo- and erythro-dihydroxyeicosatrienoic acids, respectively. The Vmax of EET hydrolysis by rat intact RBCs (2.35 ± 0.24 pmol/min/108 RBCs for 14,15-trans-EET) decreased by approximately 2 to 3-fold sequentially from 14,15-, 11,12- to 8,9-EETs for both cis- and trans-isomers. The Vmax of trans-EET hydrolysis by RBCs is approximately 2 to 3 times that of the corresponding cis-EETs. Incubation of EETs with recombinant murine soluble epoxide hydrolase (sEH) yielded the same geometric and regio preferences of EET hydrolysis as with rat intact RBCs. The principal epoxide hydrolase activity for EET hydrolysis (approximately 90%) is present in the erythrocyte cytosol. Western blots of sEH suggested a concentration of sEH protein to be approximately 2 μg/mg protein or 0.4 μg/109 RBCs. The apparent Km values of EETs were between 1 and 2 μM, close to the Km for purified sEH as reported. Erythrocyte hydration of cis- and trans-EETs was blocked by sEH inhibitors, 1,3-dicyclohexylurea and 4-[4-(3-adamantan-1-ylureido)cyclohexyloxy]benzoic acid. Erythrocyte sEH activity was inhibited more than 80% by 0.2% bovine serum albumin in the buffer. Preferred hydrolysis of 14,15-EETs and trans-epoxides characterizes sEH activity in RBCs that regulates the hydrolysis and release of cis- and trans-EETs in the circulation. Inhibition of sEH has produced antihypertensive and antiinflammatory effects. Because plasma trans-EETs would increase more than cis-EETs with sEH inhibition, the potential roles of trans-EETs and erythrocyte sEH in terms of circulatory regulation deserve attention.

UR - http://www.scopus.com/inward/record.url?scp=45749147793&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=45749147793&partnerID=8YFLogxK

U2 - 10.1124/jpet.107.134858

DO - 10.1124/jpet.107.134858

M3 - Article

C2 - 18445784

AN - SCOPUS:45749147793

VL - 326

SP - 330

EP - 337

JO - Journal of Pharmacology and Experimental Therapeutics

JF - Journal of Pharmacology and Experimental Therapeutics

SN - 0022-3565

IS - 1

ER -